HomeCompareREDU vs MRK

REDU vs MRK: Dividend Comparison 2026

REDU yields 58.65% · MRK yields 2.76%● Live data

vsPost on X →
After 10 years · $10,000 invested · DRIP enabled
🏆 REDU wins by $552.9K in total portfolio value
10 years
REDU
REDU
● Live price
58.65%
Share price
$3.41
Annual div
$2.00
5Y div CAGR
0%
Payout ratio
50%
After 10 yrs · $10,000 · DRIP
Portfolio value
$609.7K
Annual income
$140,032.06
Full REDU calculator →
MRK
Merck & Co. Inc.
● Live price
2.76%
Share price
$120.31
Annual div
$3.32
5Y div CAGR
32.7%
Payout ratio
50%
After 10 yrs · $10,000 · DRIP
Portfolio value
$56.8K
Annual income
$9,798.13
Full MRK calculator →

Portfolio growth — REDU vs MRK

📍 REDU pulled ahead of the other in Year 1

Annual dividend income

🛡️

Recession Test — Did They Cut Dividends?

How each stock treated shareholders during the 3 biggest crises of the last 20 years

Crisis PeriodREDUMRK
2008–2009
GFC
— No data— No data
2020 Q1–Q2
COVID
— No data— No data
2022 Q4
Rate Hike
— No data— No data
Based on dividend payment history. "Increased" = dividend grew during crisis. "Maintained" = held within 3%. "Cut" = reduced by more than 3%.
📅

Dividend Calendar Overlap

Combined, REDU + MRK cover 0 of 12 monthsgood coverage

Jan
Feb
Mar
Apr
May
Jun
Jul
Aug
Sep
Oct
Nov
Dec
REDU pays
MRK pays
Both pay
Neither
💰

Tax Bracket Optimizer

Which stock is actually better after tax? Adjust your rate to find out.

REDU
Annual income on $10K today (after 15% tax)
$4,985.34/yr
After 10yr DRIP, annual income (after tax)
$119,027.25/yr
MRK
Annual income on $10K today (after 15% tax)
$234.56/yr
After 10yr DRIP, annual income (after tax)
$8,328.41/yr
At 15% tax rate, REDU beats the other by $110,698.84/year in after-tax income after 10 years on $10,000
⚖️

Lazy Portfolio Split Optimizer

What's the optimal mix of REDU + MRK for your $10,000?

REDU: 50%MRK: 50%
100% MRK50/50100% REDU
Portfolio after 10yr
$333.2K
Annual income
$74,915.10/yr
Blended yield
22.48%
📊

Analyst Conviction Gap

Where Wall Street is most bullish on MRK right now

REDU
Analyst Ratings
3
Hold
Consensus: Hold
MRK
Analyst Ratings
25
Buy
11
Hold
1
Sell
Consensus: Buy
Price Target
$128.54
+6.8% upside vs current
Range: $100.00 — $150.00
Altman Z
4.0
Piotroski
6/9
Analyst ratings via FMP. Altman Z-Score: >3.0 safe, 1.81–3.0 grey zone, <1.81 distress. Piotroski: 7–9 strong, 0–3 weak.
🏛️

Copy Congress — What Are Politicians Buying?

Senate & House STOCK Act disclosures (last 90 days)

REDU buys
0
MRK buys
0
No recent congressional trades found for REDU or MRK in the last 90 days.
STOCK Act mandates disclosure within 45 days of transaction. Data via FMP.Full tracker →
MetricREDUMRK
Forward yield58.65%2.76%
Annual dividend / share$2.00$3.32
Payout ratio50%50%
1-year div growth0%0%
5-year div CAGR0%32.7%
Portfolio after 10y$609.7K$56.8K
Annual income after 10y$140,032.06$9,798.13
Total dividends collected$503.4K$28.9K
Payment frequencyquarterlyquarterly
SectorStockHealthcare
Analyst consensusHoldBuy

Year-by-year: REDU vs MRK ($10,000, DRIP)

YearREDU PortfolioREDU Income/yrMRK PortfolioMRK Income/yrGap
1← crossover$16,565$5,865.10$11,206$366.19+$5.4KREDU
2$26,805$9,080.00$12,650$502.35+$14.2KREDU
3$42,413$13,731.51$14,407$694.19+$28.0KREDU
4$65,687$20,305.71$16,585$967.82+$49.1KREDU
5$99,677$29,391.42$19,342$1,363.89+$80.3KREDU
6$148,336$41,682.13$22,913$1,947.19+$125.4KREDU
7$216,692$57,972.20$27,662$2,823.89+$189.0KREDU
8$311,007$79,146.50$34,159$4,173.35+$276.8KREDU
9$438,941$106,163.49$43,337$6,308.80+$395.6KREDU
10$609,699$140,032.06$56,776$9,798.13+$552.9KREDU

REDU vs MRK: Complete Analysis 2026

REDUStock

RISE Education Cayman Ltd, through its subsidiaries, provides junior English language training services under the RISE brand in China, Hong Kong, and Singapore. The company offers a range of educational programs, services, and products, which primarily include educational courses, sale of course materials, franchise services, and study tours. It also provides educational consulting services; and academic tutoring and test preparation services. The company was founded in 2007 and is headquartered in Beijing, the People's Republic of China. RISE Education Cayman Ltd operating as a subsidiary of Bain Capital Rise Education IV Cayman Limited.

Full REDU Calculator →

MRKHealthcare

Merck & Co., Inc. operates as a healthcare company worldwide. It operates through two segments, Pharmaceutical and Animal Health. The Pharmaceutical segment offers human health pharmaceutical products in the areas of oncology, hospital acute care, immunology, neuroscience, virology, cardiovascular, and diabetes, as well as vaccine products, such as preventive pediatric, adolescent, and adult vaccines. The Animal Health segment discovers, develops, manufactures, and markets veterinary pharmaceuticals, vaccines, and health management solutions and services, as well as digitally connected identification, traceability, and monitoring products. It serves drug wholesalers and retailers, hospitals, and government agencies; managed health care providers, such as health maintenance organizations, pharmacy benefit managers, and other institutions; and physicians and physician distributors, veterinarians, and animal producers. The company has collaborations with AstraZeneca PLC; Bayer AG; Eisai Co., Ltd.; Ridgeback Biotherapeutics; and Gilead Sciences, Inc. to jointly develop and commercialize long-acting treatments in HIV. Merck & Co., Inc. was founded in 1891 and is headquartered in Kenilworth, New Jersey.

Full MRK Calculator →
📬

Get this REDU vs MRK comparison by email

Save your analysis + weekly dividend insights. Free forever.

More comparisons

REDU vs SCHDREDU vs JEPIREDU vs OREDU vs KOREDU vs MAINREDU vs JNJREDU vs ABBVREDU vs PFE

⚠️ Educational purposes only. Not financial advice. Congressional trades sourced from SEC STOCK Act filings via FMP. Past performance does not guarantee future results.